+33 (0) 4 76 45 21 20 contact@sb-peptide.com
Select Page

A6 peptide

A6 peptide – Cancer Peptides CD44 binding peptide derived from residues 136-143 of the connecting peptide domain of human urokinase plasminogen activator (uPA). Modulates CD44-mediated cell signalling but does not bind to the uPA receptor or interfere with the...

Rituximab Light chain (41-55)

Rituximab Light chain (41-55) – Cancer Peptides Rituximab is a chimeric monoclonal antibody used in the treatment of some cancers like CD20 non-Hodgkin’s lymphoma and a few autoimmune conditions such as rheumatoid arthritis. However, antibody treatment can...

Infliximab Heavy chain (46-60)

Infliximab Heavy chain (46-60) – Cancer Peptides Infliximab is a biologic medicine used in the treatment of numerous autoimmune diseases including Crohn disease, rheumatoid arthritis, and ankylosing spondylitis. Infliximab binds with high affinity to tumour...

FAM49B (190-198) Mouse

FAM49B (190-198) Mouse – Cancer Peptides Fragment of Family with sequence similarity 49 member B (FAM49B), a mitochondria-localized protein that regulates mitochondrial fission and cancer progression. Within tumour environments, such as those seen in pancreatic...

Bim BH3, Peptide IV

Bim BH3, Peptide IV – Cancer Peptides A 26-residue fragment from BH3 only protein Bim, BH3 only proteins constitute a major proportion of pro-apoptotic members of the B-cell lymphoma 2 (Bcl-2) family of apoptotic regulatory proteins and participate in...